Table II.
Characteristic | No. (%) |
---|---|
Age, years | |
≤60 | 459 (52.3) |
>60 | 418 (47.7) |
Sex | |
Male | 605 (69.0) |
Female | 272 (31.0) |
Tumor location | |
Upper | 179 (20.4) |
Middle | 137 (15.6) |
Lower | 550 (62.7) |
Entire | 11 (1.3) |
Tumor size, cm | |
≤5 | 568 (64.8) |
>5 | 309 (35.2) |
Tumor differentiation | |
Well | 44 (5.0) |
Moderately | 317 (36.1) |
Poorly | 498 (56.8) |
Undifferentiated | 18 (2.1) |
pT stage | |
T1 | 91 (10.4) |
T2 | 141 (16.1) |
T3 | 423 (48.2) |
T4a | 211 (24.1) |
T4b | 11 (1.3) |
pN stage | |
N0 | 223 (25.4) |
N1 | 175 (20.0) |
N2 | 265 (30.2) |
N3a | 146 (16.6) |
N3b | 68 (7.8) |
TNM stage | |
I | 126 (14.4) |
II | 327 (37.3) |
IIIA | 183 (20.9) |
IIIB | 175 (20.0) |
IIIC | 66 (7.5) |
MLR | |
MLR0 | 223 (25.4) |
MLR1 | 203 (23.1) |
MLR2 | 451 (51.4) |
LODDS | |
LODDS1 | 261 (29.8) |
LODDS2 | 160 (18.2) |
LODDS3 | 312 (35.6) |
LODDS4 | 144 (16.4) |
Number of LN retrieved | |
<15 | 404 (46.1) |
≥15 | 473 (53.9) |
Postoperative chemotherapy | |
Yes | 275 (31.4) |
No | 602 (68.6) |
pT, tumor depth; pN, pathological node; TNM, tumor-node-metastasis; MLR, metastatic lymph node ratio; LODDS, log odds of positive nodes; LN, lymph nodes.